Skip to content
healthcare.dev

MYXREDLIN

NDC 0338-0126, insulin human, injection, solution, from Baxter Healthcare Corporation.

Product NDC
0338-0126
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA208157
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0338-0126 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN HUMAN1 [iU]/mL

Pharmacologic classes

Insulin [CS]; Insulin [EPC]

Package NDCNDC-11Package
0338-0126-120033801261212 CONTAINER in 1 CARTON (0338-0126-12) / 100 mL in 1 CONTAINER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/afca6e80-a802-49fb-a978-5fe28a173001

Use it

Look up 0338-0126 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0338-0126 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0338-0126. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.